An anciently diverged family of RNA binding proteins maintain correct splicing of a class of ultra-long exons through cryptic splice site repression.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
02 Oct 2024
Historique:
medline: 2 10 2024
pubmed: 2 10 2024
entrez: 2 10 2024
Statut: epublish

Résumé

Previously, we showed that the germ cell-specific nuclear protein RBMXL2 represses cryptic splicing patterns during meiosis and is required for male fertility (Ehrmann et al., 2019). Here, we show that in somatic cells the similar yet ubiquitously expressed RBMX protein has similar functions. RBMX regulates a distinct class of exons that exceed the median human exon size. RBMX protein-RNA interactions are enriched within ultra-long exons, particularly within genes involved in genome stability, and repress the selection of cryptic splice sites that would compromise gene function. The

Identifiants

pubmed: 39356106
doi: 10.7554/eLife.89705
pii: 89705
doi:
pii:

Substances chimiques

RNA-Binding Proteins 0
RNA Splice Sites 0
RBMX protein, human 0
Heterogeneous-Nuclear Ribonucleoproteins 0

Banques de données

GEO
['GSE233498', 'GSE74085']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/S008039/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/W002019/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : Newcastle Liverpool Durham BBSRC Doctoral Training Partnership (BB/M011186/1)
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/P006612/1
Pays : United Kingdom

Informations de copyright

© 2023, Siachisumo, Luzzi, Aldalaqan et al.

Déclaration de conflit d'intérêts

CS, SL, SA, GH, CD, KC, MG, IY, KJ, MK, IE, GS, SC, JM, SW, YB, DE No competing interests declared

Auteurs

Chileleko Siachisumo (C)

Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, United Kingdom.

Sara Luzzi (S)

Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, United Kingdom.

Saad Aldalaqan (S)

Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, United Kingdom.

Gerald Hysenaj (G)

Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, United Kingdom.

Caroline Dalgliesh (C)

Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, United Kingdom.

Kathleen Cheung (K)

Bioinformatics Support Unit, Faculty of Medical Sciences, Newcastle University, Newcastle, United Kingdom.

Matthew R Gazzara (MR)

Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Phildelphia, United States.

Ivaylo D Yonchev (ID)

School of Biosciences, University of Sheffield, Sheffield, United Kingdom.

Katherine James (K)

School of Computing, Newcastle University, Newcastle, United Kingdom.

Mahsa Kheirollahi Chadegani (M)

Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, United Kingdom.

Ingrid E Ehrmann (IE)

Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, United Kingdom.

Graham R Smith (GR)

Bioinformatics Support Unit, Faculty of Medical Sciences, Newcastle University, Newcastle, United Kingdom.

Simon J Cockell (SJ)

Bioinformatics Support Unit, Faculty of Medical Sciences, Newcastle University, Newcastle, United Kingdom.

Jennifer Munkley (J)

Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, United Kingdom.

Stuart A Wilson (SA)

School of Biosciences, University of Sheffield, Sheffield, United Kingdom.

Yoseph Barash (Y)

Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Phildelphia, United States.

David J Elliott (DJ)

Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH